2-[1-(3,4-DIMETHOXY-PHENYL)-ETHYL]-5-METHYL-2H-PYRAZOL-3-YLAMINE
![]() |
- $378 - $777.32
- Product name: 2-[1-(3,4-DIMETHOXY-PHENYL)-ETHYL]-5-METHYL-2H-PYRAZOL-3-YLAMINE
- CAS: 957483-09-9
- MF: C14H19N3O2
- MW: 261.32
- EINECS:
- MDL Number:MFCD07186343
- Synonyms:ASINEX-REAG BAS 06502070;2-[1-(3,4-DIMETHOXY-PHENYL)-ETHYL]-5-METHYL-2H-PYRAZOL-3-YLAMINE;2-[1-(3,4-dimethoxyphenyl)ethyl]-5-methylpyrazol-3-amine;1H-Pyrazol-5-amine, 1-[1-(3,4-dimethoxyphenyl)ethyl]-3-methyl-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0089378
- Product description2-[1-(3,4-DIMETHOXY-PHENYL)-ETHYL]-5-METHYL-2H-PYRAZOL-3-YLAMINE 95.00%
- Packaging500MG
- Price$777.32
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11003204
- Product description1-(1-(3,4-Dimethoxyphenyl)ethyl)-3-methyl-1H-pyrazol-5-amine 97%
- Packaging5g
- Price$701
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number018766
- Product description2-[1-(3,4-Dimethoxy-phenyl)-ethyl]-5-methyl-2H-pyrazol-3-ylamine
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0089378 | 2-[1-(3,4-DIMETHOXY-PHENYL)-ETHYL]-5-METHYL-2H-PYRAZOL-3-YLAMINE 95.00% | 500MG | $777.32 | 2021-12-16 | Buy |
Crysdot | CD11003204 | 1-(1-(3,4-Dimethoxyphenyl)ethyl)-3-methyl-1H-pyrazol-5-amine 97% | 5g | $701 | 2021-12-16 | Buy |
Matrix Scientific | 018766 | 2-[1-(3,4-Dimethoxy-phenyl)-ethyl]-5-methyl-2H-pyrazol-3-ylamine | 1g | $378 | 2021-12-16 | Buy |
Properties
Boiling point :434.3±45.0 °C(Predicted)
Density :1.17±0.1 g/cm3(Predicted)
pka :4.36±0.10(Predicted)
Density :1.17±0.1 g/cm3(Predicted)
pka :4.36±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|